SpectraCure AB (publ)

SpectraCure AB (publ) focuses on clinical research in primary localised prostate cancer and recurrent prostate cancer, with an emphasis on organ-confined and locally recurrent disease.

• Localised prostate cancer
• Recurrent prostate cancer

The sponsor’s research activity is centered on treatment approaches for prostate tumours that remain confined to the gland or return after prior therapy.